Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Buck

Showing results (121-130 of 400) with videos related to

Pageof 40
Sort By:
International Journal of Molecular Sciences|May 25, 2024
Modelling the In Vivo and Ex Vivo DNA Damage Response after Internal Irradiation of Blood from Patients with Thyroid CancerSarah Schumann, Harry Scherthan, Philipp E Hartrampf, et al.
Methods (San Diego, Calif.)|September 17, 2017
Chemokine receptor - Directed imaging and therapyAndreas K Buck, Antje Stolzenburg, Heribert Hänscheid, et al.
Molecular Imaging and Biology|January 4, 2024
Evaluating the Patterns of FAPI Uptake in the Shoulder Joint: a Preliminary Study Comparing with FDG Uptake in Oncological StudiesYohji Matsusaka, Rudolf A Werner, Sebastian E Serfling, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2010
PET/CT with 18F-FLT is unlikely to cause significant hepatorenal or hematologic toxicityMalik E Juweid, Damita Thomas, Yusuf Menda, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 11, 2016
Intraindividual tumor heterogeneity in NET - Further insight by C-X-C motif chemokine receptor 4-directed imagingRudolf A Werner, Alexander Weich, Andreas Schirbel, et al.
Nuclear Medicine and Biology|March 27, 2007
Synthesis and biodistribution of 3'-fluoro-5-[(131)I]iodo-2'-deoxyuridine: a comparative study of [(131)I]FLIdU and [(18)F]FLTAndreas T J Vogg, Andreas K Buck, Michaela Schmid, et al.
Annals of Nuclear Medicine|August 15, 2018
CXCR4-directed theranostics in oncology and inflammationMalte Kircher, Peter Herhaus, Margret Schottelius, et al.
Clinical Nuclear Medicine|March 17, 2023
Partial Response Upon Peptide Receptor Radionuclide Therapy in a Highly Proliferative Pancreatic Neuroendocrine TumorAlexander Weich, Sebastian E Serfling, Steven P Rowe, et al.
Oncotarget|March 13, 2015
11C-Methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myelomaKatharina Lückerath, Constantin Lapa, Christa Albert, et al.
Plos One|December 31, 2013
Targeting paraprotein biosynthesis for non-invasive characterization of myeloma biologyKatharina Lückerath, Constantin Lapa, Annika Spahmann, et al.
Pageof 40

Showing results (121-130 of 400) with videos related to

Sort By:
Pageof 40
International Journal of Molecular Sciences|May 25, 2024
Modelling the In Vivo and Ex Vivo DNA Damage Response after Internal Irradiation of Blood from Patients with Thyroid CancerSarah Schumann, Harry Scherthan, Philipp E Hartrampf, et al.
Methods (San Diego, Calif.)|September 17, 2017
Chemokine receptor - Directed imaging and therapyAndreas K Buck, Antje Stolzenburg, Heribert Hänscheid, et al.
Molecular Imaging and Biology|January 4, 2024
Evaluating the Patterns of FAPI Uptake in the Shoulder Joint: a Preliminary Study Comparing with FDG Uptake in Oncological StudiesYohji Matsusaka, Rudolf A Werner, Sebastian E Serfling, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2010
PET/CT with 18F-FLT is unlikely to cause significant hepatorenal or hematologic toxicityMalik E Juweid, Damita Thomas, Yusuf Menda, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 11, 2016
Intraindividual tumor heterogeneity in NET - Further insight by C-X-C motif chemokine receptor 4-directed imagingRudolf A Werner, Alexander Weich, Andreas Schirbel, et al.
Nuclear Medicine and Biology|March 27, 2007
Synthesis and biodistribution of 3'-fluoro-5-[(131)I]iodo-2'-deoxyuridine: a comparative study of [(131)I]FLIdU and [(18)F]FLTAndreas T J Vogg, Andreas K Buck, Michaela Schmid, et al.
Annals of Nuclear Medicine|August 15, 2018
CXCR4-directed theranostics in oncology and inflammationMalte Kircher, Peter Herhaus, Margret Schottelius, et al.
Clinical Nuclear Medicine|March 17, 2023
Partial Response Upon Peptide Receptor Radionuclide Therapy in a Highly Proliferative Pancreatic Neuroendocrine TumorAlexander Weich, Sebastian E Serfling, Steven P Rowe, et al.
Oncotarget|March 13, 2015
11C-Methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myelomaKatharina Lückerath, Constantin Lapa, Christa Albert, et al.
Plos One|December 31, 2013
Targeting paraprotein biosynthesis for non-invasive characterization of myeloma biologyKatharina Lückerath, Constantin Lapa, Annika Spahmann, et al.
Pageof 40